Skip links and navigation

News & events

Apply for QScript Consumer Reference Group and public-facing videos

Closing date: 5pm, Tuesday 28 January 2020

Health consumers and/or carers are invited to take part in a project aimed at educating the public and medical professionals about QScript, Queensland’s real-time prescription monitoring system 

Insight is seeking to partner with consumers and/or carers who have lived experience of persistent pain, anxiety, sleep problems or Attention Deficit Hyperactivity Disorder (ADHD). Consumers will have the opportunity to participate in the development of education and communication relating to Queensland’s new real time prescription monitoring system, QScript.

Insight are developing a series of videos to educate the public and medical professionals about QScript. Consumers partnering on this project will inform and guide the content of the videos, and potentially appear in the videos.

Who is conducting this project – Insight

Queensland Health have contracted Insight, an education provider, to develop education modules relating to Queensland Health’s Program of Work, real time prescription monitoring system. Insight will be conducting this work on behalf of Queensland Health. Read more about Insight:

What are monitored medicines?

‘Monitored medicines’ are medicines identified by Queensland Health as potentially presenting a high risk of harm to patients as a result of misuse, abuse, diversion, substance use disorder and/or overdose. Because of this risk, the dispensing of these medicines is closely monitored to help ensure safe use.

These monitored medicines are most commonly used to treat pain, insomnia, attention deficit hyperactivity disorder (ADHD), and mental health difficulties such as anxiety.

What is real-time reporting of monitored medicines?

Providing real-time prescription information directly to treatment providers is one means of significantly improving prescribing and dispensing decisions and reducing harms from inappropriate and/or unsafe use of high-risk prescription medicines.

For further details on the program of work involving Queensland’s real time prescription monitoring system, QScript.

Consumer Opportunity

Initial Consumer Reference Group meeting: the week of 10th  February 2020

Filming to be scheduled: between  17th  February to 16th March 2020

  1. Join the Consumer Reference Group to inform the below pieces of work. This Reference Group will continue throughout the implementation of the program and any further marketing or educational information.
  2. QScript public-facing video. Queensland Health is currently engaging pharmacists, medical practitioners and health consumers to be filmed in a video to educate the public about QScript. The public facing video will be featured in various channels, primarily social media and online education modules for clinicians. Consumers will be asked to:
  • Provide feedback on the script developed for the public video and;
  • Consumer representatives who are comfortable with being featured (filmed, delivering a piece to camera) in the promotional video. See public facing script here.
  1. Clinician facing education – Honest Conversations. As with the public-facing video, consumers will be asked to:
  • Provide feedback on the script, and
  • Consumer representatives who are comfortable with being featured (filmed, delivering a piece to camera) in the promotional video.

Overview of Consumer group

See terms of reference

Terms of Reference

See terms of reference

Consumer role

The role of the successful applicants will be to:

  • Actively participate in the consumer advisory group
  • Actively participate in the projects outlined above
  • Confidently advocate on behalf of health consumers and carers
  • Bring a consumer/ carer perspective to all discussions and decision-making
  • Possess a good understanding of matters that affect people receiving monitored medicines

Who is it for?

This opportunity would suit a consumer or carer representative:

  • With a lived experience or caring for someone with persistent pain, anxiety, sleep problems (insomnia) or ADHD.
  • Who is comfortable being featured on film and delivering a script to the camera
  • Have an understanding of the Queensland Health system and experience providing consumer feedback

Time and location

Timing and frequency of meetings: see terms of reference. The Consumer Reference Group meeting will occur in the week of  10th February 2020 to contribute to the public facing video and clinician facing education. Filming is aimed to be completed between 17th February to 16th March 2020.

Location of meetings: Brisbane. Teleconferencing/dial in options can be made available for members in remote locations. See terms of reference.

Remuneration and Support

Insight will remunerate and reimburse consumers for their time and expenses in alignment with Health Consumers Queensland’s Position Statement as per details below:

  • $187 for meetings 4 hours and under (including pre-reading and travel time).
  • OR $40 per hour including preparation time.

The consumer/or carer will also be reimbursed for any travel or parking expenses.

Payments will be made in the form of a Coles/Woolworths voucher (including travel expenses).

For consumers based outside of Brisbane in regional, rural or remote locations, Videoconferencing and Teleconferencing facilities will be made available.

Insight staff will also provide support to those consumers who require additional assistance in order to participate.  Contact Insight directly to discuss on (07) 3837 5655.

How to apply

Please complete this consumer application form and return to by 5pm on Tuesday, 28 January 2020

For assistance please contact Health Consumers Queensland via or by phone on 07 3012 9090.